Psoriasis drug sickens patient

The FDA issued a warning yesterday confirming that another patient taking the psoriasis drug Raptiva developed a rare form of brain infection called progressive multifocal leukoencephalopathy (PML). The warning came after Genentech reported that a 47 year old man in Germany had been hospitalized for the infection. Two other patients--a 70 year old and a 73 year old--died of PML in October and November of last year. All of the patients who developed PML were taking the psoriasis drug for more th

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The FDA issued a warning yesterday confirming that another patient taking the psoriasis drug Raptiva developed a rare form of brain infection called progressive multifocal leukoencephalopathy (PML). The warning came after Genentech reported that a 47 year old man in Germany had been hospitalized for the infection. Two other patients--a 70 year old and a 73 year old--died of PML in October and November of last year. All of the patients who developed PML were taking the psoriasis drug for more than three years. The drug already carries a black-box warning, the sternest warning required by the FDA. In response, Tara Cooper, spokesperson for Genentech, said, "As a company, we take the risk of PML very seriously and we're working with the FDA to put the right plan in place to protect people's safety. We're looking at all possible approaches, including a risk minimization plan." Since its approval in 2003, more than 46,000 patients have taken Raptiva to combat moderate and severe chronic plaque psoriasis, she said. PML occurs in people with weakened immune systems--organ transplant and AIDS patients, those with cancers like Hodgkin's disease, and those taking immunosuppressant drugs. It occurs when a normally harmless virus, called Polyomavirus JC, flares up and attacks the myelin in the brain. Three patients developed PML while taking the multiple sclerosis drug Tysabri before it was pulled from the market in 2005. Since it was reintroduced in 2006 with more stringent restrictions and warnings, four more cases have been reported, the last in December, 2008.
**__Related stories:__***linkurl:MS drug sickens patient;http://www.the-scientist.com/blog/display/55285/
[16th December 2008]*linkurl: Genentech Builds a Blockbuster-free Road to Billions;http://www.the-scientist.com/article/display/14751/
[7th June 2004]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tia Ghose

    This person does not yet have a bio.
Share
Image of a woman in a microbiology lab whose hair is caught on fire from a Bunsen burner.
April 1, 2025, Issue 1

Bunsen Burners and Bad Hair Days

Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.

View this Issue
Faster Fluid Measurements for Formulation Development

Meet Honeybun and Breeze Through Viscometry in Formulation Development

Unchained Labs
Conceptual image of biochemical laboratory sample preparation showing glassware and chemical formulas in the foreground and a scientist holding a pipette in the background.

Taking the Guesswork Out of Quality Control Standards

sartorius logo
An illustration of PFAS bubbles in front of a blue sky with clouds.

PFAS: The Forever Chemicals

sartorius logo
Unlocking the Unattainable in Gene Construction

Unlocking the Unattainable in Gene Construction

dna-script-primarylogo-digital

Products

Atelerix

Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China

Green Cooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Thermo Fisher Logo
Singleron Avatar

Singleron Biotechnologies and Hamilton Bonaduz AG Announce the Launch of Tensor to Advance Single Cell Sequencing Automation

Zymo Research Logo

Zymo Research Launches Research Grant to Empower Mapping the RNome